搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
最新
最佳匹配
资讯
2 天
Kymera Therapeutics股票目标价被Brookline Capital下调至65美元
Investing.com - Brookline Capital Markets将Kymera Therapeutics (NASDAQ: KYMR )的目标价从70.00美元下调至65.00美元,同时维持对该股的"买入"评级。新目标价较目前44.79美元的交易价格有显著上涨空间, InvestingPro 数据显示分析师普遍持看涨观点。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Central Texas flash floods
X CEO resigns
Cause of death revealed
Ex-doctor refuses to answer
Midair collision in Manitoba
Family members swept away
Los Angeles joins ACLU suit
Eyes NYC, DC takeover
Discharged from hospital
American Kennel Club sued
Floats 200% pharma tariffs
Milan airport tragedy
Turkish court bans Grok
Announces anti-graft plan
Philly workers to end strike
Nebraska sues GM
Chinese man charged
Christian Horner sacked
US sanctions NK hacker
Guatemala earthquakes
Russia batters Ukraine
Greece blocks asylum claims
Hosts West African leaders
To buy Verona Pharma
'Click-to-cancel' blocked
Invests in EssilorLuxottica
Hits $4 trillion market cap
New Mexico flooding
Harvard faces subpoenas
5-yr extension w/ Thunder
反馈